Trial Details

TERMINATED
Basic Information
Clinical ID c1291
Identifier NCT01004185
Trial Title Assessing the Safety/Efficacy of Asacol Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Asacol 400 mg|DRUG: Asacol 400 mg
Participant Information
Sponsor Warner Chilcott
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-10-09
Primary Completion Date 2025-03-11
Completion Date 2025-03-11